Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone

Details for Australian Patent Application No. 2002345086 (hide)

Owner Bayer HealthCare AG

Inventors Mertin, Dirk; Block, Wolfgang; Hamann, Hans-Jurgen

Agent Davies Collison Cave

Pub. Number AU-B-2002345086

PCT Number PCT/EP02/07417

PCT Pub. Number WO2003/007995

Priority 101 34 719.7 17.07.01 DE

Filing date 4 July 2002

Wipo publication date 3 March 2003

Acceptance publication date 24 May 2007

International Classifications

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/18 (2006.01) Medicinal preparations characterised by special physical form - Adsorbates

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 101 34 719.7 17.07.01 DE

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002345086

24 May 2007 Application Accepted

  Published as AU-B-2002345086

4 October 2007 Standard Patent Sealed

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002345087-PRODUCTION OF ENANTIOMER PURE 3R, 5S- (+) NATRIUM ERYTHRO- (E)7-'4-(4-FLUOROPHENYL)-2, 6-DIISOPROPYL-5-METHOXYMETHY L-PYRID-3-YL!-3, 5-DIHYDROXY-HEPT-6-E-NOATE

2002345085-SUBSTITUTED $G(G)-LACTONE COMPOUNDS SERVING AS NMDA ANTAGONISTS